Targeting CCR9: Advancing Precision Therapies for Inflammatory Bowel Disease
Time: 12:00 pm
day: Day Two
Details:
- Leveraging CCR9 inhibition to improve therapeutic targeting and address IBD heterogeneitys
- Exploring clinical outcomes and patient stratification strategies for CCR9-targeted therapies
- Innovating treatment pathways to optimize safety and efficacy in precision medicine for IBD
